Gadolinium-based Contrast Agents for Cardiac MRI: Use of Linear and Macrocyclic Agents with Associated Safety Profile from 154 779 European Patients

Ítems similars

• Acute adverse events in cardiac MR imaging with gadolinium-based contrast agents: results from the European Society of Cardiovascular Radiology (ESCR) MRCT Registry in 72,839 patients
  per: Uhlig, Johannes, et al.
  Publicat: (2019)
• Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis
  per: Forslin, Y., et al.
  Publicat: (2019)
• Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model
  per: Kartamihardja, A Adhipatria P, et al.
  Publicat: (2016)
• Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents
  per: Lohrke, Jessica, et al.
  Publicat: (2017)
• Induction of a type I interferon signature in normal human monocytes by gadolinium-based contrast agents: comparison of linear and macrocyclic agents
  per: Wermuth, P J, et al.
  Publicat: (2014)